Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W1934622736', 'doi': 'https://doi.org/10.18632/oncotarget.5382', 'title': 'Application of functional vincristine plus dasatinib liposomes to deletion of vasculogenic mimicry channels in triple-negative breast cancer', 'display_name': 'Application of functional vincristine plus dasatinib liposomes to deletion of vasculogenic mimicry channels in triple-negative breast cancer', 'publication_year': 2015, 'publication_date': '2015-09-28', 'ids': {'openalex': 'https://openalex.org/W1934622736', 'doi': 'https://doi.org/10.18632/oncotarget.5382', 'mag': '1934622736', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/26429872', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/4742200'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.18632/oncotarget.5382', 'pdf_url': 'https://www.oncotarget.com/article/5382/pdf/', 'source': {'id': 'https://openalex.org/S126644158', 'display_name': 'Oncotarget', 'issn_l': '1949-2553', 'issn': ['1949-2553'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316297', 'host_organization_name': 'Impact Journals LLC', 'host_organization_lineage': ['https://openalex.org/P4310316297'], 'host_organization_lineage_names': ['Impact Journals LLC'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'gold', 'oa_url': 'https://www.oncotarget.com/article/5382/pdf/', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5005958218', 'display_name': 'Zeng Fan', 'orcid': 'https://orcid.org/0000-0002-3033-4920'}, 'institutions': [{'id': 'https://openalex.org/I20231570', 'display_name': 'Peking University', 'ror': 'https://ror.org/02v51f717', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I20231570']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Fan Zeng', 'raw_affiliation_strings': ['Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.'], 'affiliations': [{'raw_affiliation_string': 'Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.', 'institution_ids': ['https://openalex.org/I20231570']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5055458303', 'display_name': 'Rui Jü', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I20231570', 'display_name': 'Peking University', 'ror': 'https://ror.org/02v51f717', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I20231570']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Rui-Jun Ju', 'raw_affiliation_strings': ['Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.'], 'affiliations': [{'raw_affiliation_string': 'Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.', 'institution_ids': ['https://openalex.org/I20231570']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100349548', 'display_name': 'Lei Liu', 'orcid': 'https://orcid.org/0000-0002-3630-3674'}, 'institutions': [{'id': 'https://openalex.org/I20231570', 'display_name': 'Peking University', 'ror': 'https://ror.org/02v51f717', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I20231570']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Lei Liu', 'raw_affiliation_strings': ['Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.'], 'affiliations': [{'raw_affiliation_string': 'Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.', 'institution_ids': ['https://openalex.org/I20231570']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100824143', 'display_name': 'Hong-Jun Xie', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I20231570', 'display_name': 'Peking University', 'ror': 'https://ror.org/02v51f717', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I20231570']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Hong-Jun Xie', 'raw_affiliation_strings': ['Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.'], 'affiliations': [{'raw_affiliation_string': 'Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.', 'institution_ids': ['https://openalex.org/I20231570']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5060317580', 'display_name': 'Li-Min Mu', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I20231570', 'display_name': 'Peking University', 'ror': 'https://ror.org/02v51f717', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I20231570']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Li-Min Mu', 'raw_affiliation_strings': ['Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.'], 'affiliations': [{'raw_affiliation_string': 'Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.', 'institution_ids': ['https://openalex.org/I20231570']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5061484039', 'display_name': 'Qing Zhao', 'orcid': 'https://orcid.org/0000-0003-3374-6901'}, 'institutions': [{'id': 'https://openalex.org/I20231570', 'display_name': 'Peking University', 'ror': 'https://ror.org/02v51f717', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I20231570']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Yao Zhao', 'raw_affiliation_strings': ['Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.'], 'affiliations': [{'raw_affiliation_string': 'Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.', 'institution_ids': ['https://openalex.org/I20231570']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100395084', 'display_name': 'Yan Yan', 'orcid': 'https://orcid.org/0000-0002-9187-9318'}, 'institutions': [{'id': 'https://openalex.org/I20231570', 'display_name': 'Peking University', 'ror': 'https://ror.org/02v51f717', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I20231570']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Yan Yan', 'raw_affiliation_strings': ['Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.'], 'affiliations': [{'raw_affiliation_string': 'Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.', 'institution_ids': ['https://openalex.org/I20231570']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100509170', 'display_name': 'Huihui Ying', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I20231570', 'display_name': 'Peking University', 'ror': 'https://ror.org/02v51f717', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I20231570']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Ying-Jie Hu', 'raw_affiliation_strings': ['Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.'], 'affiliations': [{'raw_affiliation_string': 'Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.', 'institution_ids': ['https://openalex.org/I20231570']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102071757', 'display_name': 'Jia-Shuan Wu', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I20231570', 'display_name': 'Peking University', 'ror': 'https://ror.org/02v51f717', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I20231570']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Jia-Shuan Wu', 'raw_affiliation_strings': ['Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.'], 'affiliations': [{'raw_affiliation_string': 'Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.', 'institution_ids': ['https://openalex.org/I20231570']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5069362421', 'display_name': 'Wan‐Liang Lu', 'orcid': 'https://orcid.org/0000-0002-5651-4890'}, 'institutions': [{'id': 'https://openalex.org/I20231570', 'display_name': 'Peking University', 'ror': 'https://ror.org/02v51f717', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I20231570']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Wan-Liang Lu', 'raw_affiliation_strings': ['Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.'], 'affiliations': [{'raw_affiliation_string': 'Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.', 'institution_ids': ['https://openalex.org/I20231570']}]}], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 2.359, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 48, 'citation_normalized_percentile': {'value': 0.780137, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 96, 'max': 97}, 'biblio': {'volume': '6', 'issue': '34', 'first_page': '36625', 'last_page': '36642'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10422', 'display_name': 'Molecular Mechanisms of Angiogenesis and Vascular Function', 'score': 0.9983, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10422', 'display_name': 'Molecular Mechanisms of Angiogenesis and Vascular Function', 'score': 0.9983, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10336', 'display_name': 'Cancer Stem Cells and Tumor Metastasis', 'score': 0.9969, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10782', 'display_name': 'Nanotechnology and Imaging for Cancer Therapy and Diagnosis', 'score': 0.9945, 'subfield': {'id': 'https://openalex.org/subfields/2204', 'display_name': 'Biomedical Engineering'}, 'field': {'id': 'https://openalex.org/fields/22', 'display_name': 'Engineering'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/vasculogenic-mimicry', 'display_name': 'Vasculogenic mimicry', 'score': 0.9071299}, {'id': 'https://openalex.org/keywords/triple-negative-breast-cancer', 'display_name': 'Triple-negative breast cancer', 'score': 0.65286434}, {'id': 'https://openalex.org/keywords/tumor-vasculature', 'display_name': 'tumor vasculature', 'score': 0.547045}, {'id': 'https://openalex.org/keywords/vascular-normalization', 'display_name': 'vascular normalization', 'score': 0.52337}, {'id': 'https://openalex.org/keywords/tumor-targeting', 'display_name': 'Tumor Targeting', 'score': 0.501559}], 'concepts': [{'id': 'https://openalex.org/C2779944901', 'wikidata': 'https://www.wikidata.org/wiki/Q25324157', 'display_name': 'Vasculogenic mimicry', 'level': 4, 'score': 0.9071299}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.67643666}, {'id': 'https://openalex.org/C2780110267', 'wikidata': 'https://www.wikidata.org/wiki/Q7843332', 'display_name': 'Triple-negative breast cancer', 'level': 4, 'score': 0.65286434}, {'id': 'https://openalex.org/C2779536868', 'wikidata': 'https://www.wikidata.org/wiki/Q419940', 'display_name': 'Dasatinib', 'level': 4, 'score': 0.6505204}, {'id': 'https://openalex.org/C530470458', 'wikidata': 'https://www.wikidata.org/wiki/Q128581', 'display_name': 'Breast cancer', 'level': 3, 'score': 0.5179152}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.46093813}, {'id': 'https://openalex.org/C185154212', 'wikidata': 'https://www.wikidata.org/wiki/Q410454', 'display_name': 'Liposome', 'level': 2, 'score': 0.45813325}, {'id': 'https://openalex.org/C190283241', 'wikidata': 'https://www.wikidata.org/wiki/Q14599311', 'display_name': 'Apoptosis', 'level': 2, 'score': 0.44666514}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.43543985}, {'id': 'https://openalex.org/C2779429289', 'wikidata': 'https://www.wikidata.org/wiki/Q408977', 'display_name': 'Vincristine', 'level': 4, 'score': 0.4304529}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.3874995}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.35045418}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.3309358}, {'id': 'https://openalex.org/C2779013556', 'wikidata': 'https://www.wikidata.org/wiki/Q181876', 'display_name': 'Metastasis', 'level': 3, 'score': 0.16175684}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.12913567}, {'id': 'https://openalex.org/C2776755627', 'wikidata': 'https://www.wikidata.org/wiki/Q408524', 'display_name': 'Cyclophosphamide', 'level': 3, 'score': 0.091887176}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.08164337}, {'id': 'https://openalex.org/C2777583451', 'wikidata': 'https://www.wikidata.org/wiki/Q177094', 'display_name': 'Imatinib', 'level': 3, 'score': 0.07778558}, {'id': 'https://openalex.org/C2778729363', 'wikidata': 'https://www.wikidata.org/wiki/Q11688946', 'display_name': 'Myeloid leukemia', 'level': 2, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D064726', 'descriptor_name': 'Triple Negative Breast Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017209', 'descriptor_name': 'Apoptosis', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D017209', 'descriptor_name': 'Apoptosis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D045744', 'descriptor_name': 'Cell Line, Tumor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000069439', 'descriptor_name': 'Dasatinib', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D000069439', 'descriptor_name': 'Dasatinib', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004195', 'descriptor_name': 'Disease Models, Animal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008081', 'descriptor_name': 'Liposomes', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D008081', 'descriptor_name': 'Liposomes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051379', 'descriptor_name': 'Mice', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008807', 'descriptor_name': 'Mice, Inbred BALB C', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008819', 'descriptor_name': 'Mice, Nude', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011897', 'descriptor_name': 'Random Allocation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D064726', 'descriptor_name': 'Triple Negative Breast Neoplasms', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': False}, {'descriptor_ui': 'D064726', 'descriptor_name': 'Triple Negative Breast Neoplasms', 'qualifier_ui': 'Q000098', 'qualifier_name': 'blood supply', 'is_major_topic': False}, {'descriptor_ui': 'D064726', 'descriptor_name': 'Triple Negative Breast Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014750', 'descriptor_name': 'Vincristine', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D014750', 'descriptor_name': 'Vincristine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D023041', 'descriptor_name': 'Xenograft Model Antitumor Assays', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 4, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.18632/oncotarget.5382', 'pdf_url': 'https://www.oncotarget.com/article/5382/pdf/', 'source': {'id': 'https://openalex.org/S126644158', 'display_name': 'Oncotarget', 'issn_l': '1949-2553', 'issn': ['1949-2553'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316297', 'host_organization_name': 'Impact Journals LLC', 'host_organization_lineage': ['https://openalex.org/P4310316297'], 'host_organization_lineage_names': ['Impact Journals LLC'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc4742200', 'pdf_url': 'https://europepmc.org/articles/pmc4742200?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742200', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/26429872', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.18632/oncotarget.5382', 'pdf_url': 'https://www.oncotarget.com/article/5382/pdf/', 'source': {'id': 'https://openalex.org/S126644158', 'display_name': 'Oncotarget', 'issn_l': '1949-2553', 'issn': ['1949-2553'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316297', 'host_organization_name': 'Impact Journals LLC', 'host_organization_lineage': ['https://openalex.org/P4310316297'], 'host_organization_lineage_names': ['Impact Journals LLC'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'score': 0.75, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 47, 'referenced_works': ['https://openalex.org/W1484264845', 'https://openalex.org/W1550146738', 'https://openalex.org/W1762977116', 'https://openalex.org/W1830559355', 'https://openalex.org/W1921625252', 'https://openalex.org/W1932917546', 'https://openalex.org/W1966727713', 'https://openalex.org/W1969388062', 'https://openalex.org/W1971519347', 'https://openalex.org/W1979300653', 'https://openalex.org/W1980775178', 'https://openalex.org/W1982117697', 'https://openalex.org/W1982951756', 'https://openalex.org/W1985241728', 'https://openalex.org/W1988698939', 'https://openalex.org/W1993232728', 'https://openalex.org/W1998947557', 'https://openalex.org/W2003973314', 'https://openalex.org/W2008376982', 'https://openalex.org/W2011017763', 'https://openalex.org/W2022114707', 'https://openalex.org/W2023611106', 'https://openalex.org/W2027542963', 'https://openalex.org/W2030177283', 'https://openalex.org/W2032012444', 'https://openalex.org/W2035558311', 'https://openalex.org/W2047520487', 'https://openalex.org/W2049723284', 'https://openalex.org/W2062238282', 'https://openalex.org/W2069872909', 'https://openalex.org/W2093829133', 'https://openalex.org/W2094938270', 'https://openalex.org/W2096391616', 'https://openalex.org/W2099335989', 'https://openalex.org/W2104327581', 'https://openalex.org/W2106787323', 'https://openalex.org/W2107029948', 'https://openalex.org/W2111877855', 'https://openalex.org/W2116361774', 'https://openalex.org/W2148154454', 'https://openalex.org/W2152998293', 'https://openalex.org/W2158561889', 'https://openalex.org/W2160527918', 'https://openalex.org/W2172249877', 'https://openalex.org/W2325707043', 'https://openalex.org/W2467546421', 'https://openalex.org/W2620241325'], 'related_works': ['https://openalex.org/W4389045871', 'https://openalex.org/W3032635277', 'https://openalex.org/W3029176637', 'https://openalex.org/W2946864316', 'https://openalex.org/W2383395762', 'https://openalex.org/W2381764896', 'https://openalex.org/W2364641918', 'https://openalex.org/W2350964810', 'https://openalex.org/W2151837479', 'https://openalex.org/W2116361774'], 'abstract_inverted_index': {'//': [0], 'Fan': [1], 'Zeng': [2], '1': [3, 7, 11, 15, 19, 23, 27, 31, 35, 39, 40], ',': [4, 8, 12, 16, 20, 24, 28, 32, 36], 'Rui-Jun': [5], 'Ju': [6], 'Lei': [9], 'Liu': [10], 'Hong-Jun': [13], 'Xie': [14], 'Li-Min': [17], 'Mu': [18], 'Yao': [21], 'Zhao': [22], 'Yan': [25, 26], 'Ying-Jie': [29], 'Hu': [30], 'Jia-Shuan': [33], 'Wu': [34], 'Wan-Liang': [37, 70], 'Lu': [38], 'Beijing': [41, 65], 'Key': [42, 52], 'Laboratory': [43, 53], 'of': [44, 54, 60, 123, 176, 184, 188, 196, 200, 204, 212, 224, 266, 288, 294], 'Molecular': [45], 'Pharmaceutics': [46], 'and': [47, 56, 158, 192, 202, 209, 235, 239, 258], 'New': [48], 'Drug': [49], 'System,': [50], 'State': [51], 'Natural': [55], 'Biomimetic': [57], 'Drugs,': [58], 'School': [59], 'Pharmaceutical': [61], 'Sciences,': [62], 'Peking': [63], 'University,': [64], '100191,': [66], 'China': [67], 'Correspondence': [68], 'to:': [69], 'Lu,': [71], 'e-mail:': [72], '[email protected]': [73], 'Keywords:': [74], 'functional': [75, 131, 277], 'liposome,': [76], 'vincristine,': [77], 'dasatinib,': [78], 'vasculogenic': [79, 114], 'mimicry': [80, 115], 'channel,': [81], 'triple-negative': [82, 102], 'breast': [83, 103], 'cancer': [84, 104, 109, 124], 'Received:': [85], 'July': [86], '12,': [87], '2015': [88, 92, 96], 'Accepted:': [89], 'September': [90, 94], '16,': [91], 'Published:': [93], '28,': [95], 'ABSTRACT': [97], 'Standard': [98], 'chemotherapy': [99], 'cannot': [100], 'eradicate': [101], '(TNBC)': [105], 'while': [106], 'the': [107, 113, 121, 130, 167, 171, 174, 182, 210, 218, 242, 245, 250, 252, 259, 270, 275, 286], 'residual': [108], 'cells': [110, 157], 'readily': [111], 'form': [112], '(VM)': [116], 'channels,': [117], 'which': [118, 222], 'lead': [119], 'to': [120, 146], 'relapse': [122], 'after': [125], 'treatment.': [126], 'In': [127, 273], 'this': [128, 148], 'study,': [129], 'vincristine': [132], 'plus': [133], 'dasatinib': [134], 'liposomes,': [135], 'modified': [136], 'by': [137], 'a': [138, 282], 'targeting': [139], 'molecule': [140], 'DSPE-PEG': [141], '2000': [142], '-c(RGDyK),': [143], 'were': [144, 152], 'fabricated': [145], 'address': [147], 'issue.': [149], 'The': [150, 164], 'investigations': [151], 'performed': [153], 'on': [154, 217], 'TNBC': [155, 290], 'MDA-MB-231': [156, 159], 'xenografts': [160], 'in': [161, 170, 249, 255, 269], 'nude': [162], 'mice.': [163, 272], 'liposomes': [165, 243, 279], 'exhibited': [166], 'superior': [168], 'performances': [169], 'following': [172], 'aspects:': [173], 'enhancement': [175], 'cellular': [177], 'uptake': [178], 'via': [179, 186, 215], 'targeted': [180], 'action;': [181], 'induction': [183], 'apoptosis': [185], 'activation': [187], 'caspase': [189], '8,': [190], '9,': [191], '3,': [193], 'increased': [194, 253], 'expression': [195, 199], 'Bax,': [197], 'decreased': [198], 'Mcl-1,': [201], 'generation': [203], 'reactive': [205], 'oxygen': [206], 'species': [207], '(ROS);': [208], 'deletion': [211, 265, 293], 'VM': [213, 219, 267, 295], 'channels': [214, 268], 'inhibitions': [216], 'channel': [220], 'indicators,': [221], 'consisted': [223], 'vascular': [225], 'endothelial-cadherin': [226], '(VE-Cad),': [227], 'focal': [228], 'adhesion': [229], 'kinase': [230], '(FAK),': [231], 'phosphatidylinositide': [232], '3-kinase': [233], '(PI3K),': [234], 'matrix': [236], 'metallopeptidases': [237], '(MMP-2,': [238], 'MMP-9).': [240], 'Furthermore,': [241], 'displayed': [244], 'prolonged': [246], 'circulation': [247], 'time': [248], 'blood,': [251], 'accumulation': [254], 'tumor': [256], 'tissue,': [257], 'improved': [260], 'therapeutic': [261], 'efficacy': [262], 'along': [263, 291], 'with': [264, 292], 'TNBC-bearing': [271], 'conclusion,': [274], 'nanostructured': [276], 'drug-loaded': [278], 'may': [280], 'provide': [281], 'promising': [283], 'strategy': [284], 'for': [285], 'treatment': [287], 'invasive': [289], 'channels.': [296]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1934622736', 'counts_by_year': [{'year': 2024, 'cited_by_count': 2}, {'year': 2023, 'cited_by_count': 7}, {'year': 2022, 'cited_by_count': 4}, {'year': 2021, 'cited_by_count': 8}, {'year': 2020, 'cited_by_count': 4}, {'year': 2019, 'cited_by_count': 5}, {'year': 2018, 'cited_by_count': 8}, {'year': 2017, 'cited_by_count': 10}], 'updated_date': '2024-09-10T07:49:16.011149', 'created_date': '2016-06-24'}